Making patients’ lives safer and more livable
We redefine drug delivery by replacing injections with oral formulations to increase patient compliance and provide safe medication around the world
NovoArc GmbH was founded in October 2021 and we are currently expanding our product portfolio
By education David is a process engineer and holds a PhD in the field of biotechnology, but at heart he is an entrepreneur. Through various activities and trainings, he acquired skills in the field of leadership, company culture, financials and strategic planning. He is an innovative and outgoing person who likes to turn ideas into reality. David is CEO and co-founder of NovoArc.
In his PhD Thesis Julian investigated biotechnological applications of extremophilic microorganisms. In the last few years he developed the underlying technology necessary to produce NovoArc´s special ether lipids in the required quality and quantity. Because of his great knowledge in this field and his spirit of innovation Julian is CTO, managing director and co-founder of NovoArc.
Oliver is Prof. for Biotechnology and Biochemical Engineering at TU Wien. His expertise in industrial R&D, his scientific competence (>160 publications) and his wide international network in the biotech industry (80% projects in cooperation with major pharmaceutical companies) are extremely valuable to NovoArc. Oliver is scientific advisor and co-founder of NovoArc.
Lipid Purification & Modification
Max studied and worked at Technische Universität Wien, MGH Harvard and UC Berkeley. He is a highly qualified and very creative synthetic chemist, who is further expanding NovoArc’s product portfolio.
Christina studied Biochemistry and Molecular Biomedicine and focused on liposome formulation during her Master Thesis at Medical University Graz. With the gained knowledge she is a great asset to the NovoArc Team. Her main focus is the formulation of Archaeosomes with different active pharmaceutical ingredients.
Philipp studied Technical Chemistry at TU Wien and focused on lipid production during his Master Thesis. Philipp is a very accurate and precise person who is responsible for the lipid production as well as analytics.
Viktor is currently doing his PhD at Technical University Vienna with focus on the effects of growth conditions on the lipid composition of different archaeal species and their influence on Lipid Nanoparticle properties. As a part time employee Viktor is supporting the team in the field of cultivation, analytics and formulation.
Helene is studying Medical and Pharmaceutical Biotechnology at IMC Krems. Her Bachlor Thesis focuses on the cultivation of Archaea. Currently Helene is doing her practical training semester at NovoArc.
Introducing our Advisors
All this would not be possible without the support from experts in the field. We highly appreciate the help from our advisory board.
Prof. Markus Zeitlinger
Medical University of Vienna
Dr. Sylvia Nanz
Dr. Silvio Wuschko
Dr. Andreas Wagner
PD Dr. habil. Simon Drescher
Phospholipid Research Center